Liposome Production via Continuous Dilution Mixing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing lipid vesicles, such as liposomes, often involve harsh conditions that can denature phospholipids and encapsulated drugs, and are not scalable for mass production, with limited site-specific delivery of therapeutic agents due to rapid clearance by the reticuloendothelial system.
Innovation Solution
A process and apparatus for rapidly producing lipid vesicles at low pressure, involving continuous stepwise dilution of an organic lipid solution with an aqueous solution, allowing for high encapsulation efficiency of therapeutic agents like nucleic acids, proteins, and drugs, without the need for static mixers or specialized extrusion equipment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods (sonication, French press extrusion, ether infusion) are used to produce liposomes, then liposome formation is achieved, but harsh conditions cause denaturation of phospholipids and encapsulated drugs
Solution Approach 1:
The invention changes the physical parameters of liposome formation by using a continuous flow mixing process at ambient temperature and pressure, replacing harsh mechanical or thermal methods. The rapid mixing in a laminar flow regime creates vesicles under gentle conditions that preserve the integrity of phospholipids and encapsulated therapeutic agents.
Solution Approach 2:
The invention replaces mechanical disruption methods (sonication, French press extrusion) with a fluid dynamic approach using controlled laminar flow mixing. The vesicle formation is driven by diffusion and interfacial phenomena rather than mechanical force, eliminating the denaturation caused by harsh mechanical treatment.
2Productivity
If conventional liposome production methods are used, then liposomes are formed, but the process is not scalable for mass production of large volumes
Solution Approach 1:
The invention employs a continuous flow process where aqueous and organic lipid solutions are continuously mixed in a flow cell, enabling uninterrupted production of liposomes. This continuous operation allows for scalable mass production without the batch-to-batch variability and downtime associated with conventional batch processing methods.
Solution Approach 2:
The flow cell apparatus is a simple, versatile device that can produce various types of liposomes (unilamellar, multilamellar, large, small) by adjusting flow rates and solution compositions, without requiring specialized equipment for each liposome type. This universality enhances scalability and reduces equipment complexity.
3Manufacturing precision
If conventional ethanol dilution method is used, then liposomes are formed, but the resulting vesicles are heterogenous in size and contain mixture of unilamellar and multilamellar vesicles
Solution Approach 1:
The invention uses dynamic control of flow rates in a laminar flow regime to control the mixing process and vesicle formation kinetics. By maintaining steady, controlled flow conditions, the process produces liposomes with consistent size and structure. The continuous flow ensures uniform mixing and vesicle formation throughout the process.
Solution Approach 2:
The flow cell creates localized mixing zones with controlled diffusion gradients, allowing uniform vesicle formation throughout the mixing region. The laminar flow ensures that all portions of the solutions experience similar mixing conditions, producing homogeneous liposomes with consistent size and lamellar structure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the scalable production of lipid vesicles with high encapsulation efficiency, specifically up to 90%, and avoids the limitations of existing methods by forming vesicles instantaneously and maintaining therapeutic agent encapsulation during the formation process.
Implementation Method 1
mixing the aqueous solution with the organic lipid solution, wherein the organic lipid solution undergoes a continuous stepwise dilution to produce a liposome
Implementation Method 2
mixing the aqueous solution with the organic lipid solution... to produce a liposome
Data Source
AI summary
The present invention provides apparatus and processes for producing liposomes. By providing a buffer solution in a first reservoir, and a lipid solution in a second reservoir, continuously diluting the lipid solution with the buffer solution in a mixing chamber produces a liposome. The lipid solution preferably comprises an organic solvent, such as a lower alkanol.